FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN
Delisted
FUSN was delisted on the 3rd of June, 2024.
28 hedge funds and large institutions have $219M invested in Fusion Pharmaceuticals Inc. Common Shares in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-4
Holders Change %
-12.5%
% of All Funds
0.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
–
Increased
4
Reduced
4
Closed
3
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$3K
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$23.7M |
| 2 |
Morgan Stanley
New York
|
$808K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$165K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$25.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $7K | – | – | – |
|
|
S
27
SignatureFD
Atlanta,
Georgia
| $2K | – | – | – |
|
|
APA
28
American Portfolios Advisors
Holbrook,
New York
| $233 | – | – | – |
|
|
E
29
Ergoteles
New York
| – | -$46K | -11,000 | Closed |
|
30
Bank Julius Baer & Co
Zurich,
Switzerland
| – | -$8K | -2,000 | Closed |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| – | -$5K | -1,160 | Closed |
|